Triple Ring Technologies, a co-development firm that helps innovators and entrepreneurs develop breakthrough science-based technologies, is pleased to announce the addition of Greg Kovacs, MD, Ph.D., as Chief Medical Officer. In this role, Kovacs will lead efforts to turn engineering advances into meaningful clinical solutions that improve patient outcomes and achieve commercial success. Areas of focus include medical electronics, wearable devices, microfluidics, and medical systems engineering. 

“We are thrilled to have Greg join the Triple Ring team,” said Joe Heanue, Ph.D., CEO. “He is tremendously well-respected for his innovation at the boundaries of engineering, life sciences, and medicine. We’re confident that his energy and insight will be invaluable as we partner with our clients to solve hard problems, develop new products, and launch new ventures. I’m also very pleased that he will be a key mentor to the younger engineers and scientists who are drawn to Triple Ring as a great place to work on a variety of challenging projects at the start of their careers.”

Kovacs has a long list of distinguished accomplishments spanning academia, industry, and government service. He is an Emeritus Professor of Electrical Engineering at Stanford University, and for years had a courtesy appointment in the Department of Medicine, Division of Cardiovascular Medicine. His research at Stanford included the development of non-invasive instruments for cardiovascular medicine; microfabricated sensors; analog electronics; titration of medical care via embedded systems; and remote delivery of laboratory electronics education. He co-founded the Bioengineering Department and led the initial development of the bioengineering graduate core curriculum sequence. Kovacs has published over 180 peer-reviewed articles, has been granted 72 patents, and has designed a large number of electronic circuits and systems.

Kovacs has extensive industry experience co-founding companies, including Cepheid, which has shipped several hundred million nucleic acid diagnostics, and PhysioWave, developer of noninvasive cardiovascular risk assessment devices. He was a founder and Chief Technical Advisor of Malibu IQ, a private equity fund created to commercialize the intellectual property portfolio of HRL (formerly Hughes Research Laboratories).

Kovacs has a rich history of service to DoD, DoE, NASA and other government agencies. In 2003, he served as the Investigation Scientist for the debris team of the Columbia Accident Investigation Board at the Kennedy Space Center, Florida, then as Engineering/Medical Liaison on the Spacecraft Crew Survival Integration Investigation Team (SCSIIT) of the Johnson Space Center. From 2008 through 2010 he was Director of the Microelectronics Technology Office at DARPA, leading deployment of a total $1.6B for DoD-relevant and basic-science research.

“I am absolutely delighted to be joining Triple Ring as CMO,” said Kovacs. “It is the job I was made for, and it allows me to bring my background in engineering and medicine to bear on meaningful clinical problems, hopefully seeing them through to clinical use. The best part, though, is the brilliant, yet humble, and friendly team, and the open, collaborative environment at Triple Ring.” 

Triple Ring Technologies is a co-development company, partnering with clients, primarily in medtech and life sciences, to create new technologies, launch innovative projects, and start new ventures. Their capabilities span strategic investment, incubation, early R&D, product development, manufacturing, regulatory approval, and market access.  They have personnel nationwide, including offices in Silicon Valley & Boston.

See the full press release:

https://www.newswire.com/

The Triple Ring team will be participating in the upcoming 4D Meets AI – Advancing Drugs, Devices, Diagnostics, and Digital Health through the Power of Artificial Intelligence virtual partnering conference by Life Science Nation, September 17-18.

We’ll be there March 17th and 18th.